HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder Companies Teams With Google Cloud For AI That Informs R&D, Enchants Consumers

Executive Summary

The firm is extending its partnership with Google LLC’s Google Cloud to use generative AI to monitor consumer sentiment and feedback in real time, incorporate trends in its R&D, and enrich digital consumer experiences.

You may also be interested in...



Estee Lauder Companies Expands Virtual Try-On To Google Search, Social Media

The Estee Lauder Companies is making its virtual try-on tools more widely available, allowing consumers to use the technology without leaving the ‘eco-system’ of Google Search, YouTube and Snapchat. Digital try-on is now available across nine Lauder brands in more than 40 markets, says Lauder executive Tara Sparks.

Obsessed: 3D Virtual Beauty Stores Are Outperforming ‘Bland’ E-Commerce Experiences

Beauty marketers with 3D virtual stores are seeing bottom-line key performance indicator improvements compared with traditional e-commerce, including longer visits and higher average product orders, says virtual shopping interface designer Obsess, Inc.

Rembrand’s Generative AI Is Placing L’Oréal Products In YouTuber Videos Post-Production

Backed by L’Oréal’s venture capital fund, Palo Altos, CA-based Rembrand uses its Generative AI Fusion platform to place photorealistic brand and product images in post-production video content. CEO Omar Tawakol discusses the model which “makes the brand part of the story and not an interruption to it.”

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel